Iwata, Y., Katayama, Y., Okuno, Y., & Wakabayashi, S. (2018). Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model. Oncotarget.
استشهاد بنمط شيكاغوIwata, Yuko, Yoshimi Katayama, Yasushi Okuno, و Shigeo Wakabayashi. "Novel Inhibitor Candidates of TRPV2 Prevent Damage of Dystrophic Myocytes and Ameliorate against Dilated Cardiomyopathy in a Hamster Model." Oncotarget 2018.
MLA استشهادIwata, Yuko, Yoshimi Katayama, Yasushi Okuno, و Shigeo Wakabayashi. "Novel Inhibitor Candidates of TRPV2 Prevent Damage of Dystrophic Myocytes and Ameliorate against Dilated Cardiomyopathy in a Hamster Model." Oncotarget 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.